These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 533809)

  • 1. [Symposium on major histocompatibility antigens (HLA) and diseases: supplement (author's transl)].
    Yanase T
    Nihon Naika Gakkai Zasshi; 1979 Nov; 68(11):1389-90. PubMed ID: 533809
    [No Abstract]   [Full Text] [Related]  

  • 2. [Symposium on major histocompatibility antigens (HLA) and diseases. (5) HLA and psoriasis (author's transl)].
    Tsuji K
    Nihon Naika Gakkai Zasshi; 1979 Nov; 68(11):1402-5. PubMed ID: 533810
    [No Abstract]   [Full Text] [Related]  

  • 3. [Symposium on major histocompatibility antigens (HLA) and diseases. (3) HLA types in rheumatic disease (author's transl)].
    Tanimoto K
    Nihon Naika Gakkai Zasshi; 1979 Nov; 68(11):1391-4. PubMed ID: 93137
    [No Abstract]   [Full Text] [Related]  

  • 4. [Symposium on major histocompatibility antigens (HLA) and diseases. (2) New B-cell alloantigen loci in the HLA-D region (author's transl)].
    Katagiri M
    Nihon Naika Gakkai Zasshi; 1979 Nov; 68(11):1384. PubMed ID: 316443
    [No Abstract]   [Full Text] [Related]  

  • 5. [Symposium on major histocompatibility antigens (HLA) and diseases. (1) Association between immune responsiveness and HLA specificities (author's transl)].
    Sasazuki T
    Nihon Naika Gakkai Zasshi; 1979 Nov; 68(11):1380-3. PubMed ID: 93136
    [No Abstract]   [Full Text] [Related]  

  • 6. [Symposium on major histocompatibility antigens (HLA) and diseases. (4) HLA and disease-heart valular disease and aortitis syndrome (author's transl)].
    Naito S
    Nihon Naika Gakkai Zasshi; 1979 Nov; 68(11):1395-9. PubMed ID: 42662
    [No Abstract]   [Full Text] [Related]  

  • 7. [Symposium on major histocompatibility antigens (HLA) and diseases. Supplement: genetic factor in Takayasu disease (author's transl)].
    Numano F
    Nihon Naika Gakkai Zasshi; 1979 Nov; 68(11):1400-1. PubMed ID: 42663
    [No Abstract]   [Full Text] [Related]  

  • 8. [Genetic recombination within the HLA system (author's transl)].
    Ercilla MG; Arriaga F; Martorell J; Castillo R; Vives J
    Sangre (Barc); 1980; 25(6):999-1008. PubMed ID: 6939140
    [No Abstract]   [Full Text] [Related]  

  • 9. [Symposium on major histocompatibility antigens (HLA) and diseases (author's transl)].
    Nihon Naika Gakkai Zasshi; 1979 Nov; 68(11):1379-423. PubMed ID: 42661
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recombination between HLA-B and HLA-D loci of the major histocompatibility system in man (author's transl)].
    Buc M; Nyulassy S; Hegyi V; Busová B; Stefanovic J
    Cas Lek Cesk; 1978 Sep; 117(38-39):1199-203. PubMed ID: 709593
    [No Abstract]   [Full Text] [Related]  

  • 11. [Major HLA histocompatibility system as a possible genetic marker in haemophilia A and Von Willebrand's disease (author's transl)].
    Ustariz CR; Arce S; Almaguer M; Almagro D; Hernández P; Ballester JM; Pérez S; Corral JF
    Sangre (Barc); 1978; 23(3):314-9. PubMed ID: 307822
    [No Abstract]   [Full Text] [Related]  

  • 12. [Symposium on major histocompatibility antigens (HLA) and diseases. (6) HLA associated factors contributing to the development of liver cirrhosis (author's transl)].
    Ohkubo A
    Nihon Naika Gakkai Zasshi; 1979 Nov; 68(11):1406-10. PubMed ID: 533811
    [No Abstract]   [Full Text] [Related]  

  • 13. [HLA antigen and Willebrand's disease (author's transl)].
    Goudemand J; Mazurier C; Parquet-Gernez A; Goudemand M
    Pathol Biol (Paris); 1977 Apr; 25(4):241-3. PubMed ID: 327406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HLA system and collagen diseases (author's transl)].
    Bueno M; Pérez-González J; Sarria A
    An Esp Pediatr; 1981 Jul; 15(1):13-22. PubMed ID: 6797335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rheumatic diseases and the histocompatibility complex (author's transl)].
    Valenzuela Ravest F
    Rev Med Chil; 1981 Aug; 109(8):809-12. PubMed ID: 6979080
    [No Abstract]   [Full Text] [Related]  

  • 16. [HLA system and malignant diseases (author's transl)].
    Feingold N
    Bull Cancer; 1978; 65(1):79-82. PubMed ID: 667376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic markers and disease susceptibility (author's transl)].
    Dausset J; Degos L
    Rev Epidemiol Sante Publique; 1979; 27(5-6):369-79. PubMed ID: 298943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Histocompatibility patterns in multiple sclerosis. Findings of an epidemiological study (author's transl)].
    Poser S; Ritter G; Bauer HJ; Kuwert EK; Höher PG; Grosse-Wilde H; Hierholzer E
    Nervenarzt; 1981 Jun; 52(6):326-8. PubMed ID: 6973699
    [No Abstract]   [Full Text] [Related]  

  • 19. [Altered cytotoxic lymphocyte reactivity the cause of different results in studies of the relationship between HLA-antigens and disease (author's transl)].
    Májský A
    Cas Lek Cesk; 1975 Dec; 114(49):1518-20. PubMed ID: 1203938
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chances of finding HLA identical bone marrow donors among relations (author's transl)].
    Májský A; Kout M; Herzog P; Soucek J; Novák JT; Potmĕsilová I
    Cas Lek Cesk; 1981 May; 120(18):547-50. PubMed ID: 7028267
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.